FR2925856B1 - SPECIFIC OPERATIVE PROCEDURE TO ENERGIZE THE ASSOCIATION OF DIFFERENT NATURAL INGREDIENTS AND OPTIMIZE THEIR PROPERTIES TO CONFERATE THEM MORE EFFICIENT AGAINST HERPES PUSHING - Google Patents

SPECIFIC OPERATIVE PROCEDURE TO ENERGIZE THE ASSOCIATION OF DIFFERENT NATURAL INGREDIENTS AND OPTIMIZE THEIR PROPERTIES TO CONFERATE THEM MORE EFFICIENT AGAINST HERPES PUSHING

Info

Publication number
FR2925856B1
FR2925856B1 FR0709158A FR0709158A FR2925856B1 FR 2925856 B1 FR2925856 B1 FR 2925856B1 FR 0709158 A FR0709158 A FR 0709158A FR 0709158 A FR0709158 A FR 0709158A FR 2925856 B1 FR2925856 B1 FR 2925856B1
Authority
FR
France
Prior art keywords
conferate
energize
optimize
pushing
association
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0709158A
Other languages
French (fr)
Other versions
FR2925856A1 (en
Inventor
Patrick Mamou
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to FR0709158A priority Critical patent/FR2925856B1/en
Publication of FR2925856A1 publication Critical patent/FR2925856A1/en
Application granted granted Critical
Publication of FR2925856B1 publication Critical patent/FR2925856B1/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/63—Arthropods
    • A61K35/64—Insects, e.g. bees, wasps or fleas
    • A61K35/644—Beeswax; Propolis; Royal jelly; Honey
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A61K36/8962—Allium, e.g. garden onion, leek, garlic or chives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Virology (AREA)
  • Insects & Arthropods (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Animal Husbandry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Plant Substances (AREA)
FR0709158A 2007-12-28 2007-12-28 SPECIFIC OPERATIVE PROCEDURE TO ENERGIZE THE ASSOCIATION OF DIFFERENT NATURAL INGREDIENTS AND OPTIMIZE THEIR PROPERTIES TO CONFERATE THEM MORE EFFICIENT AGAINST HERPES PUSHING Expired - Fee Related FR2925856B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR0709158A FR2925856B1 (en) 2007-12-28 2007-12-28 SPECIFIC OPERATIVE PROCEDURE TO ENERGIZE THE ASSOCIATION OF DIFFERENT NATURAL INGREDIENTS AND OPTIMIZE THEIR PROPERTIES TO CONFERATE THEM MORE EFFICIENT AGAINST HERPES PUSHING

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0709158A FR2925856B1 (en) 2007-12-28 2007-12-28 SPECIFIC OPERATIVE PROCEDURE TO ENERGIZE THE ASSOCIATION OF DIFFERENT NATURAL INGREDIENTS AND OPTIMIZE THEIR PROPERTIES TO CONFERATE THEM MORE EFFICIENT AGAINST HERPES PUSHING

Publications (2)

Publication Number Publication Date
FR2925856A1 FR2925856A1 (en) 2009-07-03
FR2925856B1 true FR2925856B1 (en) 2010-11-19

Family

ID=39645351

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0709158A Expired - Fee Related FR2925856B1 (en) 2007-12-28 2007-12-28 SPECIFIC OPERATIVE PROCEDURE TO ENERGIZE THE ASSOCIATION OF DIFFERENT NATURAL INGREDIENTS AND OPTIMIZE THEIR PROPERTIES TO CONFERATE THEM MORE EFFICIENT AGAINST HERPES PUSHING

Country Status (1)

Country Link
FR (1) FR2925856B1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201712501D0 (en) * 2017-08-03 2017-09-20 Neem Biotech Ltd An antimicrobial composition

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4795636A (en) * 1985-11-20 1989-01-03 Tsuei Julia J Method for treating genital and oral herpes
WO1996014064A1 (en) * 1994-11-07 1996-05-17 Strecker, Robert, B. Method and composition for antiviral therapy
AU4915997A (en) * 1996-10-24 1998-05-15 Nextech Enterprises International Composition and method for topical treatment of active herpesviral infecti ons
WO2004075854A2 (en) * 2003-02-26 2004-09-10 Program For Appropriate Technology In Health Microbicidal compositions and method of use
AU2004220541B2 (en) * 2003-03-12 2009-03-26 Epitome Pharmaceuticals Limited Rapidly absorbing lipophilic skin compositions and uses therefor
WO2007009185A1 (en) * 2005-07-19 2007-01-25 Honey Research & Development Pty Ltd Therapeutic honey and method of producing same

Also Published As

Publication number Publication date
FR2925856A1 (en) 2009-07-03

Similar Documents

Publication Publication Date Title
IL250641B (en) Pharmaceutical compositions for inhibiting nhe-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
HUS1900038I1 (en) Inhibitors of sodium glucose co-transporter 2 and methods of their use
HRP20190059T1 (en) Compositions for the treatment of pain and/or inflammation
PT2601961T (en) Compositions comprising lag-3 and therapeutic antibodies and their uses in the treatment of cancer
ZA201000991B (en) Pharmaceutical compositions and methods of treating dry eye disorders
IL202525A (en) Stabilizer system of natural ingredients for use in frozen confectionery
WO2008106102A9 (en) Inhibitors of rtp801 and their use in disease treatment
EP2125855A4 (en) Methods and compositions for the treatment of cancer or other diseases
EP2125711A4 (en) 2 -substituted- 3 -phenylpropionic acid derivatives and their use in the treatment of inflammatory bowel disease
ZA201109384B (en) Novel pyrimidine derivatives and their use in the treatment of cancer and further diseases
EP2384198A4 (en) Pharmaceutical compositions and methods of treating neurological insults
ZA201001473B (en) Compositions and methods for the modification of physiological responses in plants
HK1170485A1 (en) 1,2,4-thiazolidin-3-one derivatives and their use in the treatment of cancer 124--3-
EP2094281A4 (en) Use of lipid conjugates in the treatment of diseases or disorders of the eye
IL204741A (en) Ceramide derivatives for use in the treatment of polycystic kidney disease and pharmaceutical compositions comprising these derivatives
EP2170404A4 (en) Compositions comprising human egfr-sirna and methods of use
EP2200564A4 (en) Compositions and methods of inhibiting n-acylethanolamine-hydrolyzing acid amidase
EP2459200A4 (en) Pharmaceutical compositions comprising modified fucans for use in the treatment of fibrous adhesions and other disorders
EP1986682A4 (en) Methods and compositions related to targeting tumors and wounds
PT2185581E (en) Methods and compositions useful in the treatment of mucositis
IL207965A0 (en) N-substitutedbenzenepropanamide ofr denzenepropenamide derivatives for use in the treatment of pain and inflammation
IL198721A0 (en) Acat inhibitors and their use in the prevention or treatment of fibrosis
ZA201108106B (en) Use of phthalimide derivatives in the treatment of diseases
FR2925856B1 (en) SPECIFIC OPERATIVE PROCEDURE TO ENERGIZE THE ASSOCIATION OF DIFFERENT NATURAL INGREDIENTS AND OPTIMIZE THEIR PROPERTIES TO CONFERATE THEM MORE EFFICIENT AGAINST HERPES PUSHING
EP2373327A4 (en) Composition comprising expression or activity inhibitors of ninjurin 1 for the prevention and treatment of inflammatory disease

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 9

PLFP Fee payment

Year of fee payment: 10

PLFP Fee payment

Year of fee payment: 11

ST Notification of lapse

Effective date: 20190906